Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8073
+0.0281 (3.61%)
At close: May 22, 2026, 4:00 PM EDT
0.8000
-0.0073 (-0.90%)
After-hours: May 22, 2026, 7:10 PM EDT
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $9.69 million as of May 22, 2026. Its market cap has increased by 50.18% in one year.
Market Cap
9.69M
Enterprise Value
11.09M
1-Year Change
50.18%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $9.69M, a decrease of -72.52%. That is a compound annual growth rate of -24.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 9.69M | 46.00% |
| Dec 31, 2025 | 6.64M | -21.39% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TherapeuticsMD | 24.07M |
| Aytu BioPharma | 23.08M |
| Apimeds Pharmaceuticals US | 17.48M |
| China SXT Pharmaceuticals | 10.33M |
| Caring Brands | 8.09M |
| cbdMD | 7.85M |
| Akanda | 7.75M |
| InMed Pharmaceuticals | 7.19M |